Sort
53,477 grants matching “addiction”
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$735,618Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2010 · DA
Mechanisms Mediating Cocaine Abuse in Socially Housed Female and Male Monkeys
$735,577Michael A Nader · Wake Forest University Health Sciences · R01 · FY2018 · DA
Development of Nociceptin Receptor Agonists for Post-Traumatic Stress Disorder
$735,539Shaun P Brothers · University Of Miami School Of Medicine · R01 · FY2017 · MH
A randomized comparative effectiveness trial of nicotine pouches for cigarette substitution: A question of public health
$735,462Megan E Piper · University Of Wisconsin-Madison · R01 · FY2025 · CA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$735,387Kenner Rice · National Institute On Drug Abuse · ZIA · FY2021 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$735,387Kenner Rice · National Institute On Drug Abuse · ZIA · FY2018 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$735,387Kenner Rice · National Institute On Drug Abuse · ZIA · FY2019 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$735,387Kenner Rice · National Institute On Drug Abuse · ZIA · FY2020 · DA
Development of Nociceptin Receptor Agonists for Post-Traumatic Stress Disorder
$735,350Shaun P Brothers · University Of Miami School Of Medicine · R01 · FY2018 · MH
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders
$735,333Martin H Teicher · Mclean Hospital · R01 · FY2023 · DA
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders
$735,333Martin H Teicher · Mclean Hospital · R01 · FY2022 · DA
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders
$735,333Martin H Teicher · Mclean Hospital · R01 · FY2021 · DA
Protective effects of DA antagonists Vs METH induced toxicity in rats
$735,306Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2014 · DA
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection
$735,253Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2020 · DA
Telemedicine for Treatment of Opioid Use Disorder
$735,192Haiden A. Huskamp · Harvard Medical School · R01 · FY2019 · DA
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
$735,149Kimberly Page · University Of New Mexico Health Scis Ctr · UG1 · FY2021 · DA
Collaborative Care for Primary Care Patients with Alcohol Use Disorders
$735,081Katharine Anthony Bradley · Kaiser Foundation Health Plan Of Washington · R01 · FY2013 · AA
Building Interdisciplinary Research Careers in Women's Health at UC Davis
$735,051Nancy E. Lane · University Of California At Davis · K12 · FY2023 · HD
Multiscale Genetic Connectivity of Primate Social Circuits
$735,023Julie R Korenberg · University Of Utah · R01 · FY2014 · MH
Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer
$734,981Kwok Kin Wong · New York University School Of Medicine · R01 · FY2024 · CA
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
$734,961Georgios Skiniotis · Stanford University · R01 · FY2018 · NS
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders
$734,956Jennifer W Tidey · University Of Vermont & St Agric College · U54 · FY2019 · DA
Circuitry dynamics underlying opioid-dependence: Integrating structural, functional, and transcriptomic mechanisms
$734,920Gregory Corder · University Of Pennsylvania · R01 · FY2025 · DA
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
$734,866Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DA
Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples
$734,865Tyrel J Starks · Hunter College · R01 · FY2023 · DA